164 related articles for article (PubMed ID: 147349)
1. Inhibitory characteristics of lead chloride in sodium- and potassium- dependent adenosinetriphosphatase preparations derived from kidney, brain, and heart of several species.
Nechay BR; Saunders JP
J Toxicol Environ Health; 1978 Jan; 4(1):147-59. PubMed ID: 147349
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
Nechay BR; Saunders JP
J Environ Pathol Toxicol; 1978; 2(2):247-62. PubMed ID: 216760
[TBL] [Abstract][Full Text] [Related]
3. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
Coughlin RT; Akera T; McGroarty EJ; Steinbach C
Mol Pharmacol; 1987 Jul; 32(1):147-53. PubMed ID: 3037299
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of renal adenosine triphosphatase by cadmium.
Nechay BR; Sauners JP
J Pharmacol Exp Ther; 1977 Mar; 200(3):623-9. PubMed ID: 139465
[TBL] [Abstract][Full Text] [Related]
5. Membrane (Na+ + K+)-ATPase of canine brain, heart and kidney. Tissue-dependent differences in kinetic properties and the influence of purification procedures.
Choi YR; Akera T
Biochim Biophys Acta; 1978 Apr; 508(2):313-27. PubMed ID: 147705
[TBL] [Abstract][Full Text] [Related]
6. Kinetic studies on inhibition of dog heart Na+,K+-dependent ATPase by K+,Mg2+-aspartate: comparison with ouabain.
Fedelesová M; Dzurba A; Ziegelhöffer A
Recent Adv Stud Cardiac Struct Metab; 1975; 5():375-85. PubMed ID: 127359
[TBL] [Abstract][Full Text] [Related]
7. Cardiac sodium, potassium-adenosine triphosphatase as a possible site of adriamycin-induced cardiotoxicity.
Solomonson LP; Halabrin PR
Cancer Res; 1981 Feb; 41(2):570-2. PubMed ID: 6256069
[TBL] [Abstract][Full Text] [Related]
8. Lead actions on sodium-plus-potassium-activated adenosinetriphosphatase from electroplax, rat brain, and rat kidney.
Siegel GJ; Fogt SK; Hurley MJ
Adv Exp Med Biol; 1977; 84():465-93. PubMed ID: 197830
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of adenosine triphosphatase in vitro by silver nitrate and silver sulfadiazine.
Nechay BR; Saunders JP
J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):119-26. PubMed ID: 6240533
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of inhibition of human renal adenosine triphosphatases by cisplatin and chloroplatinic acid.
Nechay BR; Neldon SL
Cancer Treat Rep; 1984 Sep; 68(9):1135-41. PubMed ID: 6148141
[TBL] [Abstract][Full Text] [Related]
11. Adenosine triphosphatases of rat pancreatic islets: comparison with those of rat kidney.
Levin SR; Kasson BG; Driessen JF
J Clin Invest; 1978 Sep; 62(3):692-701. PubMed ID: 211146
[TBL] [Abstract][Full Text] [Related]
12. Effects of vanadium on different adenosinetriphosphatases and binding of 3H-labeled ouabain and calcium-45 to rat brain synaptosomes.
Mishra SK; Osborn RL; Desaiah D
J Toxicol Environ Health; 1981 Sep; 8(3):449-61. PubMed ID: 6212691
[TBL] [Abstract][Full Text] [Related]
13. Studies on (Na+ plus K+)-activated ATPase. XXXVII. Stabilization by cations of the enzyme-ouabain complex formed with Mg1+ and inorganic phosphate.
Schuurmans Stekhoven FM; De Pont JJ; Bonting SL
Biochim Biophys Acta; 1976 Jan; 419(1):137-49. PubMed ID: 128379
[TBL] [Abstract][Full Text] [Related]
14. Ouabain-sensitive adenosine triphosphatase from human kidneys.
Nechay BR; Nelson JA; Contreras RR; Sarles HE; Remmers AR; beathard GA; fish JC; Lindley JD; Brady JM; Lerman MJ
J Pharmacol Exp Ther; 1975 Feb; 192(2):303-9. PubMed ID: 123273
[TBL] [Abstract][Full Text] [Related]
15. Renal sodium-potassium-activated adenosine triphosphatase and sodium reabsorption.
Martinez-Maldonado M; Allen JC; Inagaki C; Tsaparas N; Schwartz A
J Clin Invest; 1972 Oct; 51(10):2544-51. PubMed ID: 4262518
[TBL] [Abstract][Full Text] [Related]
16. [Intrarenal distribution and ATPase inhibiting activity of cuabain in dogs (author's transl)].
Nishida H
Hokkaido Igaku Zasshi; 1975 Jan; 50(1):34-41. PubMed ID: 125217
[TBL] [Abstract][Full Text] [Related]
17. Oubain-sensitive adenosine triphosphatase from human kidneys.
Nechay BR; Nelson JA; Contreras RR; Sarles HE; Remmers AR; Beathard GA; Fish JC; Lindley JD; Brady JM; Lerman MJ
J Pharmacol Exp Ther; 1975 Feb; 192(2):303-9. PubMed ID: 123274
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Na+, K+-adenosine triphosphatase inhibition by ouabain and myocardial sodium: a computer simulation.
Akera T; Bennett RT; Olgaard MK; Brody TM
J Pharmacol Exp Ther; 1976 Nov; 199(2):287-97. PubMed ID: 135837
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance and kinetic studies of the mechanism of membrane-bound sodium and potassium ion- activated adenosine triphosphatase.
Grisham CM; Mildvan AS
J Supramol Struct; 1975; 3(3):304-13. PubMed ID: 171521
[TBL] [Abstract][Full Text] [Related]
20. Effects of patulin on the kinetics of substrate and cationic ligand activation of adenosine triphosphatase in mouse brain.
Phillips TD; Hayes AW
J Pharmacol Exp Ther; 1978 Jun; 205(3):606-16. PubMed ID: 26794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
